ID: ALA1908229

Max Phase: Preclinical

Molecular Formula: C8H14O

Molecular Weight: 126.20

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C#CC(C)OC(C)(C)C

Standard InChI:  InChI=1S/C8H14O/c1-6-7(2)9-8(3,4)5/h1,7H,2-5H3

Standard InChI Key:  FIQFHOBKZSUGLM-UHFFFAOYSA-N

Associated Targets(non-human)

Cytochrome P450 2B4 31 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cytochrome P450 2E1 34 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 126.20Molecular Weight (Monoisotopic): 126.1045AlogP: 1.82#Rotatable Bonds: 1
Polar Surface Area: 9.23Molecular Species: NEUTRALHBA: 1HBD: 0
#RO5 Violations: 0HBA (Lipinski): 1HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 1.82CX LogD: 1.82
Aromatic Rings: 0Heavy Atoms: 9QED Weighted: 0.49Np Likeness Score: 0.29

References

1. Fontana E, Dansette PM, Poli SM..  (2005)  Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity.,  (1): [PMID:16248836] [10.2174/138920005774330639]

Source